Telangana Medical Board Fills 212 Assistant Professor Posts; 221 Vacancies Remain Due to Lack of Eligible Candidates
Telangana's Medical and Health Services Recruitment Board announced selection results for Assistant Professor positions, filling 212 of 433 posts while 221 remain vacant. The unfilled positions are primarily due to the absence of qualified candidates in reserved category positions. This recruitment shortfall highlights challenges in meeting diversity requirements while maintaining academic qualification standards in medical education.
The Medical and Health Services Recruitment Board (MHSRB) in Hyderabad released selection notifications on June 10, 2026, for Assistant Professor positions across multiple medical specialties under the Directorate of Medical Education. Of 433 posts for which selection lists were announced, 212 were successfully filled while 221 remained vacant. The vacancies stem largely from insufficient qualified applicants in several reserved category positions. The original recruitment notification, issued in June 2025, aimed to fill 607 Assistant Professor posts across 34 specialties. Selection notifications for four specialties were released in April, while provisional merit lists for the remaining 30 specialties were published in May, followed by certificate verification conducted between May 22-25.
What different sources said
- The HinduCenter
Telangana MHSRB fills 212 Assistant Professor posts; 221 vacancies persist due to lack of eligible candidates
Related
Multi-Cancer Blood Test Galleri Fails Primary Trial Endpoint
A major clinical trial of Galleri, a blood test designed to detect multiple cancers early, failed to meet its primary goal of reducing late-stage cancer diagnoses when results were announced in February. Multi-cancer early detection (MCED) tests aim to improve survival rates by identifying disease at earlier, more treatable stages. The failure raises questions about the effectiveness of this promising diagnostic approach despite initial scientific enthusiasm.
Study Uses CPAP Data to Measure Social Jet Lag in Sleep Apnea Patients
Researchers analyzed CPAP adherence records from nearly 3,000 obstructive sleep apnea patients to measure social jet lag—the circadian misalignment between work and free days. About 16-21% of patients showed moderate to severe social jet lag, with prevalence highest in younger and middle-aged adults and declining after age 65. The findings suggest CPAP devices could routinely screen for circadian misalignment, potentially identifying patients who need additional behavioral or activity-based interventions.
FDA Updates Alli Label to Warn of Rare but Potentially Fatal Kidney Problems
The FDA has approved updated labeling for Alli, an over-the-counter weight loss pill, to warn of rare risks including acute kidney injury, kidney stones, and oxalate nephropathy. The agency now instructs people with kidney disease history to consult a doctor before use and directs all users to stop taking the drug if they experience symptoms like back pain, blood in urine, or leg swelling. This warning is significant because Alli is the only OTC weight loss medication available in the U.S., and approximately 40 million people have used orlistat (Alli's generic form) since its approval in 1999.